arrow
I

Irmela Jeremias

german research center for environmental health
H指数:50
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeting CD28 on T lineage malignancies with chimeric antigen receptor T cells

靶向T细胞系恶性血液肿瘤中的CD28的嵌合抗原受体T细胞

2026-10-080
OA
A platform of serially transplantable AML PDX models covering subgroups for which no cell lines exist

一种涵盖无细胞系的亚组、可连续移植的急性髓系白血病PDX模型平台

2026-10-050
OAAI
Increasing TET Expression and 5-Hydroxymethylcytosine Formation by a Carbocyclic 5-Aza-2′-deoxy-cytidine Antimetabolite

通过环状5-氮杂-2′-脱氧胞苷抗代谢物增加TET表达和5-羟基甲基胞嘧啶的形成

2026-06-210
OAAI
Author Correction: The ubiquitin ligase RNF5 determines acute myeloid leukemia growth and susceptibility to histone deacetylase inhibitors

作者更正:泛素连接酶RNF5决定急性髓系白血病的生长和对组蛋白去乙酰化酶抑制剂的敏感性

2026-06-110
OAAI
Post-transcriptional depletion of ribosome biogenesis factors engenders therapeutic vulnerabilities in NPM1-mutant AML

转录后耗竭核糖体生物发生因子在NPM1突变AML中产生治疗易感性

Blood
IF23.1
2025-06-270
OA
Potent Activity of Duocarmyin- and Mmaf-Conjugated FLT3-Directed Antibody-Drug Conjugates Towards Acute Myeloid Leukemia Stem Cells in Vitro and In Vivo

杜卡米恩和MMAF偶联的FLT3靶向抗体药物偶联物对急性髓系白血病干细胞在体外的强效活性及在体内的活性

BLOOD
IF23.1
2024-11-050
PRE
Rational combinatorial targeting by adapter CAR-T-cells (AdCAR-T) prevents antigen escape in acute myeloid leukemia
LEUKEMIA
IF13.4
2024-08-031
OAAI
Combined proteomics and CRISPR-Cas9 screens in PDX identify ADAM10 as essential for leukemia in vivo
2023-07-088
OAAI
Significance of molecular diagnostics for therapeutic decision-making in recurrent glioma
2023-05-129
OAAI
ITCC-P4: Genomic profiling and analyses of pediatric patient tumor and patient-derived xenograft (PDX) models for high throughput in vivo testing
2023-04-041
PRE
Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia

单细胞转录图谱指导car-t细胞治疗急性髓系白血病的开发

2023-03-1336
OAAI
X-linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL

X连锁凋亡蛋白抑制剂代表了复发/难治性ALL的有希望的治疗靶点

2022-11-233
OAAI
Translatome proteomics identifies autophagy as a resistance mechanism to on-target FLT3 inhibitors in acute myeloid leukemia (vol 36, pg 2396, 2022)
LEUKEMIA
IF13.4
2022-11-080
OAAI
In vivo PDX CRISPR/Cas9 screens reveal mutual therapeutic targets to overcome heterogeneous acquired chemo-resistance
LEUKEMIA
IF13.4
2022-11-048
OAAI
A Dynamic rRNA Ribomethylome Drives Stemness in Acute Myeloid Leukemia
2022-10-1925
OAAI